Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-12Clinical Trial Update: Role of Combination Therapy in Women With Refractory Overactive Bladder [NA]
A clinical trial investigating combination therapy for women with refractory overactive bladder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder [Phase 4]
A Phase 4 trial evaluating the combination of intravesical Botox injections and HoLEP surgery for benign prostatic hyperplasia and overactiv…
-
CLINICAL_TRIALS withdrawal · 2025-07-18Clinical Trial Update: Prophylactic Analgesia for Bladder Botox Injections [Phase 4]
A Phase 4 clinical trial evaluating prophylactic analgesia for bladder Botox injections has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-17Clinical Trial Update: Development of Novel Cystometrics for Overactive Bladder
A clinical trial evaluating novel cystometrics for overactive bladder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-16Clinical Trial Update: Laser Treatment of Genito-urinary Syndrome in Women [NA]
A clinical trial investigating laser treatment for genitourinary syndrome of menopause in women has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-05-29Clinical Trial Update: A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder [NA]
A sham-controlled clinical trial evaluating a wearable bladder neuromodulation system for overactive bladder has been terminated.
-
CLINICAL_TRIALS withdrawal · 2019-03-07Clinical Trial Update: Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome [Phase 4]
Phase 4 clinical trial evaluating a Beta-3 agonist for psychological distress and bladder blood flow in women with overactive bladder; the s…
-
CLINICAL_TRIALS withdrawal · 2018-07-12Clinical Trial Update: Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use [Phase 4]
Phase 4 trial evaluating Biotene Moisturizing Mouth Spray for xerostomia associated with oral oxybutynin use has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-06-08Clinical Trial Update: Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence [Phase 2]
A Phase 2 clinical trial evaluating an autologous neo-bladder construct for non-neurogenic overactive bladder with urge incontinence has bee…
-
CLINICAL_TRIALS withdrawal · 2017-06-16Clinical Trial Update: Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating intravesical instillations of BotuGel and slow-release RTGel-based Botox formulations for idiopathic o…
-
CLINICAL_TRIALS withdrawal · 2017-05-16Clinical Trial Update: Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1 [NA]
A clinical trial evaluating a posterior tibial implantable micro-stimulator for overactive bladder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-06Clinical Trial Update: Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder [Phase 4]
A Phase 4 clinical trial of solifenacin succinate vs placebo in inner-city women with overactive bladder was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-17Clinical Trial Update: A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
The randomized study comparing cystoscopy with urethral dilatation versus cystoscopy alone in women with Overactive Bladder and impaired voi…
-
CLINICAL_TRIALS withdrawal · 2016-03-16Clinical Trial Update: Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms [Phase 2]
A Phase 2 trial evaluating transcutaneous electrical nerve stimulation for overactive bladder was withdrawn, with no results reported.
-
CLINICAL_TRIALS withdrawal · 2016-03-01Clinical Trial Update: Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients [Phase 1, Phase 2]
This clinical trial update reports termination of a Phase 1/2 study evaluating intravesical botulinum toxin in TC-3 Gel for overactive bladd…
-
CLINICAL_TRIALS withdrawal · 2015-09-02Clinical Trial Update: A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication
A clinical trial assessing changes in an overactive bladder medication sponsored by Astellas Pharma Inc has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-26Clinical Trial Update: Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach. [Phase 2]
A Phase 2 clinical trial evaluating botulinum toxin type A injections for detrusor hyperreflexia in spinal cord injury was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-01-26Clinical Trial Update: Neuromodulation Implantation Settings Variation for Overactive Bladder [NA]
A clinical trial evaluating variations in neuromodulation implantation settings for overactive bladder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-26Clinical Trial Update: Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
The clinical trial evaluating the effects of antimuscarinic drugs on overactive bladder symptoms following ureteral stent insertion has been…
-
CLINICAL_TRIALS withdrawal · 2012-07-24Clinical Trial Update: Overactive Bladder (OAB) Drink Advice Study [NA]
The Overactive Bladder Drink Advice Study sponsored by Radboud University Medical Center has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-07-27Clinical Trial Update: Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder [Phase 3]
Phase 3 trial evaluating KUC-7483 for overactive bladder has been withdrawn, ending the long-term safety and efficacy assessment.